BCMIO
SGMO

Beacon Capital Management Inc (Ohio)’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Beacon Capital Management Inc (Ohio)’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-4,950
Closed -$94K – 91
2018
Q1 		$94K Hold
4,950
– – ﹤0.01% 27
2017
Q4 		$81K Hold
4,950
– – ﹤0.01% 30
2017
Q3 		$74K Hold
4,950
– – ﹤0.01% 30
2017
Q2 		$44K Hold
4,950
– – ﹤0.01% 37
2017
Q1 		$26K Hold
4,950
– – ﹤0.01% 40
2016
Q4 		$15K Hold
4,950
– – ﹤0.01% 47
2016
Q3 		$23K Hold
4,950
– – ﹤0.01% 58
2016
Q2 		$29K Hold
4,950
– – ﹤0.01% 66
2016
Q1 		$30K Hold
4,950
– – ﹤0.01% 76
2015
Q4 		$45K Hold
4,950
– – ﹤0.01% 78
2015
Q3 		$28K Hold
4,950
– – ﹤0.01% 93
2015
Q2 		$55K Hold
4,950
– – ﹤0.01% 77
2015
Q1 		$78K Hold
4,950
– – 0.01% 69
2014
Q4 		$75K Hold
4,950
– – 0.01% 70
2014
Q3 		$53K Hold
4,950
– – 0.01% 86
2014
Q2 		$76K Hold
4,950
– – 0.01% 77
2014
Q1 		$89K Buy
+4,950
New +$95.4K 0.02% 68

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Beacon Capital Management Inc (Ohio)'s SGMO Position: Q2 2018 in Review

Beacon Capital Management Inc (Ohio) sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2018, closing a stake of 4,950 shares — an estimated $94K sold.

Beacon Capital Management Inc (Ohio) first reported a position in SGMO in Q1 2014 and held it in 17 quarters. The position peaked at $94K in Q1 2018. 210 funds tracked by Wall St. Rank hold SGMO as of Q2 2018.

  • Beacon Capital Management Inc (Ohio) reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2018 after selling out during the quarter.
  • Beacon Capital Management Inc (Ohio) sold 4,950 SANGAMO THERAPEUTICS INC shares in Q2 2018, an estimated $94K.
  • Beacon Capital Management Inc (Ohio) first reported a position in SANGAMO THERAPEUTICS INC in Q1 2014 and held it in 17 quarters.
  • Beacon Capital Management Inc (Ohio)'s SANGAMO THERAPEUTICS INC position peaked at $94K in Q1 2018.
  • 210 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2018.

Based on Beacon Capital Management Inc (Ohio)'s 13F filing for Q2 2018, filed 16 Jul 2018.